Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma - La; Casce, A. S., Bociek, R. G., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., OConnor, O. A., Josephson, N., Wang, Y., Advani, R. (American Society of Hematology (ASH), 2018)
6299624
Keywords: W; WW-YZ